Live from the NIH registry
Studies recruiting near Durham right now
Top 25 of 1,669 recruiting studies, sorted by proximity — each links to its official registry page
Hyperpolarized 129Xe MRI for Imaging Pulmonary Function
Interstitial Lung Disease
Phase 2
Interventional 445 participants sought
Duke University Medical Center — Durham, North Carolina (1.0 mi)
· Sponsor: Bastiaan Driehuys
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Duke University Medical Center — Durham, North Carolina (1.0 mi)
· Sponsor: National Cancer Institute (NCI)
Observation of Environment and Reproductive-Endocrine Effects
Hypogonadism, Hypergonadism
N/A
Observational 300 participants sought
NIEHS Clinical Research Unit (CRU) — Research Triangle Park, North Carolina (6.1 mi)
· Sponsor: National Institute of Environmental Health Sciences (NIEHS)
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Lymphoma, Large B-Cell, Diffuse
Phase 2
Interventional 594 participants sought
University of North Carolina Medical Center ( Site 0136) — Chapel Hill, North Carolina (9.7 mi)
· Sponsor: Merck Sharp & Dohme LLC
Optimizing Perioperative Analgesia to Lower Pain Following Cleft Palate Surgery
Cleft Palate, Pain
Phase 4
Interventional 60 participants sought
Duke University Medical Center — Durham, North Carolina (1.0 mi)
· Sponsor: Duke University
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
Diabetic Macular Edema
Phase 1, Phase 2
Interventional 49 participants sought
North Carolina Retina Associates — Wake Forest, North Carolina (21.9 mi)
· Sponsor: Boehringer Ingelheim
A Study to Determine the Effects of ENDS Flavor Availability on Abstinence Within Smokers
Smoking, Tobacco
N/A
Interventional 1,280 participants sought
L&E Raleigh — Raleigh, North Carolina (20.6 mi)
· Sponsor: RAI Services Company
Delayed-Enhancement Cardiovascular Magnetic Resonance in Patients With Sarcoidosis
Sarcoidosis
N/A
Observational 27,000 participants sought
Duke University Medical Center — Durham, North Carolina (1.0 mi)
· Sponsor: Duke University
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Bladder Carcinoma, Ureter Carcinoma
N/A
Observational 2,020 participants sought
UNC- Chapel Hill — Chapel Hill, North Carolina (9.7 mi)
· Sponsor: Guardant Health, Inc.
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
High Grade Glioma, Diffuse Intrinsic Pontine Glioma
Phase 2
Interventional 120 participants sought
Duke Cancer Center — Durham, North Carolina (1.0 mi)
· Sponsor: Nationwide Children's Hospital
Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections
Gonorrhea, Chlamydia
Phase 4
Interventional 760 participants sought
Chapel Hill — Chapel Hill, North Carolina (9.7 mi)
· Sponsor: Westat
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
Multiple Myeloma, Relapsed/Refractory Multiple Myeloma
Phase 2
Interventional 100 participants sought
UNC Hospitals Adult Oncology Clinics — Chapel Hill, North Carolina (9.7 mi)
· Sponsor: C4 Therapeutics, Inc.
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Durham VA Medical Center — Durham, North Carolina (1.0 mi)
· Sponsor: SWOG Cancer Research Network
A Phase 1, Dose Escalation Trial of RP-A601 in Subjects With PKP2 Variant-Mediated Arrhythmogenic Cardiomyopathy (PKP2-ACM)
PKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM)
Phase 1
Interventional 9 participants sought
Duke University — Durham, North Carolina (1.0 mi)
· Sponsor: Rocket Pharmaceuticals Inc.
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Ulcerative Colitis
Phase 4
Interventional 65 participants sought
University of North Carolina — Chapel Hill, North Carolina (9.7 mi)
· Sponsor: Takeda
Study to Evaluate the REMEDY SPECTRUM GV IM Spacer Nail in the Treatment of Ankle-Related Infections
Periprosthetic Joint Infection
Phase 2
Interventional 60 participants sought
Duke University Medical Center — Durham, North Carolina (1.0 mi)
· Sponsor: OsteoRemedies, LLC
HLA Demographics Study in Adults With Type 1 Diabetes
Diabetes Mellitus, Type I
N/A
Observational 200 participants sought
University of North Carolina at Chapel Hill — Chapel Hill, North Carolina (9.7 mi)
· Sponsor: GentiBio, Inc
Waveform Capnography Compared to Colorimetric Carbon Dioxide Detection During Tracheal Intubation of Critically Ill Adults
Acute Respiratory Failure
N/A
Observational 2,092 participants sought
Duke University School of Medicine — Durham, North Carolina (1.0 mi)
· Sponsor: Brian Driver
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Urothelial Cancer, Bladder Cancer
Phase 2, Phase 3
Interventional 630 participants sought
Research Site — Chapel Hill, North Carolina (9.7 mi)
· Sponsor: Daiichi Sankyo
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
Duke Eye Center — Durham, North Carolina (1.0 mi)
· Sponsor: Genentech, Inc.
Lemborexant Treatment of Insomnia Linked to Epilepsy
Epilepsy, Sleep
Phase 3
Interventional 26 participants sought
Duke University — Durham, North Carolina (1.0 mi)
· Sponsor: University of Manitoba
A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)
Thrombocythemia, Essential, Primary Myelofibrosis
Phase 3
Interventional 400 participants sought
DUHS Duke Blood Cancer Center ( Site 6005) — Durham, North Carolina (1.0 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Raleigh, North Carolina (20.6 mi)
· Sponsor: Sameek Roychowdhury
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
Duke Cardiology — Morrisville, North Carolina (11.6 mi)
· Sponsor: Duke University
Ultrasound Simulation Case-based Workshop Implementation and Impact Assessment
Point-of-care Ultrasound, Simulation Training
N/A
Interventional 100 participants sought
Duke University Health System — Durham, North Carolina (1.0 mi)
· Sponsor: Duke University